FAGRON (FAGR.BR) Stock Price, Forecast & Analysis
EBR:FAGR • BE0003874915
FAGR.BR Key Statistics, Chart & Performance
The current stock price of FAGR.BR is 22.05 EUR. In the past month the price decreased by -4.33%. In the past year, price increased by 19.07%.
FAGR.BR Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to FAGR.BR. When comparing the yearly performance of all stocks, FAGR.BR turns out to be only a medium performer in the overall market: it outperformed 67.89% of all stocks.
FAGR.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to FAGR.BR. While FAGR.BR belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.
FAGR.BR Financial Highlights
Over the last trailing twelve months FAGR.BR reported a non-GAAP Earnings per Share(EPS) of 1.17. The EPS increased by 10.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.31% | ||
| ROA | 7.65% | ||
| ROE | 17.07% | ||
| Debt/Equity | 0.78 |
FAGR.BR Forecast & Estimates
13 analysts have analysed FAGR.BR and the average price target is 26.08 EUR. This implies a price increase of 18.29% is expected in the next year compared to the current price of 22.05.
For the next year, analysts expect an EPS growth of 11.64% and a revenue growth 9.01% for FAGR.BR
FAGR.BR Ownership
FAGR.BR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| AXNA | AMPLIFON SPA | 17.45 | 2.974B | ||
| AMP | AMPLIFON SPA | 17.11 | 2.923B | ||
| UPR | UNIPHAR PLC | 15.9 | 1.046B | ||
| ILM1 | MEDIOS AG | 11.85 | 418.874M | ||
| BLC | BASTIDE LE CONFORT MEDICAL | 13.23 | 193.094M | ||
| VME | VIROMED MEDICAL AG | N/A |
Related stock screener links
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Brussels Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About FAGR.BR
Company Profile
Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 3,989 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.
Company Info
FAGRON
Venecoweg 20A
Nazareth OOST-VLAANDEREN BE
Employees: 3989
Phone: 3280012880
FAGRON / FAGR.BR FAQ
Can you describe the business of FAGRON?
Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 3,989 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.
Can you provide the latest stock price for FAGRON?
The current stock price of FAGR.BR is 22.05 EUR. The price decreased by -0.23% in the last trading session.
What is the dividend status of FAGRON?
FAGRON (FAGR.BR) has a dividend yield of 1.19%. The yearly dividend amount is currently 0.29.
What is the ChartMill rating of FAGRON stock?
FAGR.BR has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the market expecting FAGR stock to perform?
13 analysts have analysed FAGR.BR and the average price target is 26.08 EUR. This implies a price increase of 18.29% is expected in the next year compared to the current price of 22.05.
Is FAGRON (FAGR.BR) expected to grow?
The Revenue of FAGRON (FAGR.BR) is expected to grow by 9.01% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the market capitalization of FAGR stock?
FAGRON (FAGR.BR) has a market capitalization of 1.62B EUR. This makes FAGR.BR a Small Cap stock.